The IgG4ward! Foundation guidelines on the treatment of IgG4-related disease.

Perugino CA, Alexander T, Baker MC, Brooks D, Carruthers MN, Chwalisz BK, Chen LYC, Culver EL, Danforth H, Della-Torre E, Dong L, Silva GD, Ebbo M, El-Saadany H, Falaki A, Freitag S, Gray ST, Hart PA, Hedgire SS, Hernandez-Barco Y, Hernández-Molina G, Hughes-Hallett A, Inoue D, Kambadakone AR, Kamisawa T, Karadag O, Katz G, Kawano M, Keat K, Kilian A, Kleger A, Lanzillotta M, Löhr JM, Lydston M, Martin-Nares E, Martinez-Valle F, Masamune A, Meysami A, Murphy P, Nakayamada S, Okazaki K, Park WG, Provencher A, Provencher K, Rebours V, Riddle S, Saeki T, Schleinitz N, Sharma A, Skelly K, Tanaka Y, Tomlinson JAP, Travers B, Tsuboi H, Uchida K, Umehara H, Vaglio A, Yamamoto M, Yoshifuji H, Zhang W, Stone JH, Khosroshahi A

Open source

DOI: 10.1016/s2665-9913(26)00312-7
Published: 2026 Nov 9
Container: The Lancet. Rheumatology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2665-9913-26-00312-7,
  title = {The IgG4ward! Foundation guidelines on the treatment of IgG4-related disease.},
  author = {Perugino CA and Alexander T and Baker MC and Brooks D and Carruthers MN and Chwalisz BK and Chen LYC and Culver EL and Danforth H and Della-Torre E and Dong L and Silva GD and Ebbo M and El-Saadany H and Falaki A and Freitag S and Gray ST and Hart PA and Hedgire SS and Hernandez-Barco Y and Hernández-Molina G and Hughes-Hallett A and Inoue D and Kambadakone AR and Kamisawa T and Karadag O and Katz G and Kawano M and Keat K and Kilian A and Kleger A and Lanzillotta M and Löhr JM and Lydston M and Martin-Nares E and Martinez-Valle F and Masamune A and Meysami A and Murphy P and Nakayamada S and Okazaki K and Park WG and Provencher A and Provencher K and Rebours V and Riddle S and Saeki T and Schleinitz N and Sharma A and Skelly K and Tanaka Y and Tomlinson JAP and Travers B and Tsuboi H and Uchida K and Umehara H and Vaglio A and Yamamoto M and Yoshifuji H and Zhang W and Stone JH and Khosroshahi A},
  year = {2026},
  journal = {The Lancet. Rheumatology},
  doi = {10.1016/s2665-9913(26)00312-7},
  url = {https://doi.org/10.1016/s2665-9913(26)00312-7}
}

RIS

TY  - JOUR
TI  - The IgG4ward! Foundation guidelines on the treatment of IgG4-related disease.
AU  - Perugino CA
AU  - Alexander T
AU  - Baker MC
AU  - Brooks D
AU  - Carruthers MN
AU  - Chwalisz BK
AU  - Chen LYC
AU  - Culver EL
AU  - Danforth H
AU  - Della-Torre E
AU  - Dong L
AU  - Silva GD
AU  - Ebbo M
AU  - El-Saadany H
AU  - Falaki A
AU  - Freitag S
AU  - Gray ST
AU  - Hart PA
AU  - Hedgire SS
AU  - Hernandez-Barco Y
AU  - Hernández-Molina G
AU  - Hughes-Hallett A
AU  - Inoue D
AU  - Kambadakone AR
AU  - Kamisawa T
AU  - Karadag O
AU  - Katz G
AU  - Kawano M
AU  - Keat K
AU  - Kilian A
AU  - Kleger A
AU  - Lanzillotta M
AU  - Löhr JM
AU  - Lydston M
AU  - Martin-Nares E
AU  - Martinez-Valle F
AU  - Masamune A
AU  - Meysami A
AU  - Murphy P
AU  - Nakayamada S
AU  - Okazaki K
AU  - Park WG
AU  - Provencher A
AU  - Provencher K
AU  - Rebours V
AU  - Riddle S
AU  - Saeki T
AU  - Schleinitz N
AU  - Sharma A
AU  - Skelly K
AU  - Tanaka Y
AU  - Tomlinson JAP
AU  - Travers B
AU  - Tsuboi H
AU  - Uchida K
AU  - Umehara H
AU  - Vaglio A
AU  - Yamamoto M
AU  - Yoshifuji H
AU  - Zhang W
AU  - Stone JH
AU  - Khosroshahi A
PY  - 2026
JO  - The Lancet. Rheumatology
DO  - 10.1016/s2665-9913(26)00312-7
UR  - https://doi.org/10.1016/s2665-9913(26)00312-7
ER  -

APA

CA, P., T, A., MC, B., D, B., MN, C., BK, C., LYC, C., EL, C., H, D., E, D., L, D., GD, S., M, E., H, E., A, F., S, F., ST, G., PA, H., SS, H., Y, H., G, H., A, H., D, I., AR, K., T, K., O, K., G, K., M, K., K, K., A, K., A, K., M, L., JM, L., M, L., E, M., F, M., A, M., A, M., P, M., S, N., K, O., WG, P., A, P., K, P., V, R., S, R., T, S., N, S., A, S., K, S., Y, T., JAP, T., B, T., H, T., K, U., H, U., A, V., M, Y., H, Y., W, Z., JH, S., & A, K. (2026). The IgG4ward! Foundation guidelines on the treatment of IgG4-related disease.. The Lancet. Rheumatology. https://doi.org/10.1016/s2665-9913(26)00312-7

Source records

pubmed · retrieved 2026-11-10T14:27:46.478Z